Tianlong Luo

机构：Shenzhen Polytechnic University · ORCID：0000-0002-1426-9903

发表论文 24 篇 · 总被引 200 次 · h-index 7

代表论文

• Cuproptosis illustrates tumor micro-environment features and predicts prostate cancer therapeutic sensitivity and prognosis (2023 · Life Sciences · 被引 61)
• The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment (2023 · Cell & Bioscience · 被引 29)
• Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway (2024 · Journal of Experimental & Clinical Cancer Research · 被引 21)
• MT1G , an emerging ferroptosis‐related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer (2023 · Environmental Toxicology · 被引 20)
• Assessment of treatment outcomes: cytoreductive surgery compared to radiotherapy in oligometastatic prostate cancer – an in-depth quantitative evaluation and retrospective cohort analysis (2024 · International Journal of Surgery · 被引 12)
• Socially responsible retailer’s service provision strategies for poverty and inequity alleviation in the supply chain (2023 · Computers & Industrial Engineering · 被引 11)